About 2 results found for searched term "Loncastuximab" (0.239 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24838 | Loncastuximab | Others |
| RB4v1.2 | ||
| Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL). | ||
| M24839 | Loncastuximab tesirine | Drug-Linker Conjugates for ADC |
| zz-lpyl; ADCT-402 | ||
| Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
